For the Inventor, By the Inventor

Enter assignee name

Alligator Bioscience Ab

USPTO Granted Patents = 34

CIPO Patents = 8

EPO Patents = 13

Trademarks = 3

Forward Citations = 63

Loading Chart...

Loading Chart...

75 inventors (with patents filed for the assignee):

Christina Furebring (18 out of 18 patents)

Peter Ellmark (17 out of 17 patents)

Laura Von Schantz (11 out of 11 patents)

4. Sara Fritzell (9 out of 9 patents)

5. Laura Varas (8 out of 8 patents)

6. Niina Veitonmaki (7 out of 7 patents)

7. Eva Maria Dahlen (6 out of 6 patents)

8. Anna Sall (5 out of 5 patents)

9. Per Norlen (5 out of 5 patents)

10. Roland Carlsson (5 out of 13 patents)

11. Ann-Christin Malmborg Hager (5 out of 5 patents)

12. Carl Borrebaeck (4 out of 4 patents)

13. David Bienvenue (3 out of 7 patents)

14. Gabriela Hernandez-Hoyos (3 out of 7 patents)

15. Lynda Misher (3 out of 8 patents)

34 patents: Sort by Forward Citations

1. 12448465 - Peptides (2025-10-21),

2. 12415862 - Methods and compositions (2025-09-16),

3. 12173082 - Bispecific polypeptides against CD137 (2024-12-24),

4. 11873348 - Peptides (2024-01-16),

5. 11780928 - Polypeptides (2023-10-10),

6. 11725060 - Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods (2023-08-15),

7. 11535678 - Anti-CD137 antibodies and uses thereof (2022-12-27),

8. 11312786 - Oncofetal antigen binding proteins and related compositions and methods (2022-04-26),

9. 11149090 - Combination therapies with anti CD40 antibodies (2021-10-19),

10. 11008396 - Polypeptides (2021-05-18),

11. 10774150 - Polypeptides (2020-09-15),

12. 10689454 - Anti-CD137 antibodies and uses thereof (2020-06-23),

13. 10640567 - Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells (2020-05-05),

14. 10577425 - Anti-CD40 antibodies (2020-03-03),

15. 10414815 - scFV antibody library (2019-09-17),

Alligator Bioscience AB is a Swedish biotechnology company that specializes in developing innovative immune-oncology drugs for cancer treatment. The company's focus lies in the development of tumor-directed immunotherapies using advanced antibody-based drug discovery. Alligator Bioscience aims to improve cancer patients' lives by developing novel and effective therapeutics that stimulate the body's immune system to fight cancer. For more information, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

34 Patents

#16 in Lund

#183 in Sweden

#19,016 in the World

Alligator Bioscience Ab

Forward Citations = 63

75 inventors:

Christina Furebring (18 out of 18 patents)

Peter Ellmark (17 out of 17 patents)

Laura Von Schantz (11 out of 11 patents)

4. Sara Fritzell (9 out of 9 patents)

5. Laura Varas (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…